Skip to main content
Clinical Trials/NCT04946877
NCT04946877
Unknown
N/A

Clinical Study of Comorbidities of Attention Deficit Hyperactivity in Children and Adolescents.

Assiut University0 sites200 target enrollmentMarch 1, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
Attention Deficit Hyperactivity Disorder
Sponsor
Assiut University
Enrollment
200
Primary Endpoint
Determine psychiatric comorbidities in children and adolescents with ADHD using Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid).
Last Updated
4 years ago

Overview

Brief Summary

Determine the frequency of psychiatric and neurological comorbidities in children and adolescence diagnosed with ADHD.

Detailed Description

ADHD is a common neurodevelopmental disorder characterized by hyperactivity, impulsivity, and inattention .ADHD is more often a complex disorder with a high rate of associated co-morbid conditions. Co-morbid conditions are prevalent among people with ADHD and increase its burden and complexity of management.Children with ADHD are at a higher risk than children without ADHD for developing other psychiatric disorders .Motor skill problems and Neurological soft signs are found in many neuropsychiatric conditions .NSS have been associated with inattention and behaviour difficulties for decades. Some researchers argue that these signs should be included in the diagnosis of ADHD .

Registry
clinicaltrials.gov
Start Date
March 1, 2022
End Date
October 1, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Salma Mohmed

Doctor

Assiut University

Eligibility Criteria

Inclusion Criteria

  • Age: 6-17 years.
  • Sex: both sexes will be included in the study.

Exclusion Criteria

  • Age: less than 6 years or more than 17 years.
  • Patients with major neurological deficits, cerebral palsy and uncontrolled epilepsy.
  • Patients with major psychiatric disorders e.g schizophrenia spectrum disorder.
  • Patient who refusing to participate in the study or their caregiver refusing to give informed consent.

Outcomes

Primary Outcomes

Determine psychiatric comorbidities in children and adolescents with ADHD using Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid).

Time Frame: baseline

Mini international neuropsychiatric interview for children and adolescents (M.I.N.I. Kid): is structured clinical diagnostic interview designed to assess the presence of current ICD-10 and DSM-IV psychiatric disorders in children and adolescents age 6-17 years

Secondary Outcomes

  • determinate presence of soft neurological sign in children and adolescents with ADHD using Cambridge neurological inventory.(baseline)

Similar Trials